A Phase-I, Pharmacokinetic and Pharmacodynamic Study of Darbepoetin alfa Injection, Hetero and â??ARANESP®â?? (Darbepoetin alfa Injection, Amgen), in Healthy Adult Human Subjects

Trial Profile

A Phase-I, Pharmacokinetic and Pharmacodynamic Study of Darbepoetin alfa Injection, Hetero and â??ARANESP®â?? (Darbepoetin alfa Injection, Amgen), in Healthy Adult Human Subjects

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Darbepoetin alfa (Primary) ; Darbepoetin alfa (Primary)
  • Indications Anaemia
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Hetero Drugs
  • Most Recent Events

    • 25 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top